BME Announces Expanded Availability Of The Speed Shift(TM) Nitinol Compression Fixation System Designed For Sliding Calcaneal Osteotomies
SAN ANTONIO, April 28, 2014 /PRNewswire/ — BioMedical Enterprises, Inc. (BME), a pioneer and U.S. leader in shape memory technology for small bone fixation, announced today the nationwide availablity of the Speed Shift(TM) Continuous Active Compression System.
The Speed Shift(TM) Continuous Active Compression implant is the world’s first superelastic Nitinol bone fixation device with an offset bridge to accommodate uneven bone surfaces that are procedure-specific, such as for sliding calcaneal osteotomies. This unique superelastic implant, with a stepped bridge (available in a range of sizes from 4mm to 12mm) offers the Foot & Ankle surgeon intraoperative options for reconstruction of flatfoot and high arch conditions. In addition, the new Speed Shift System is a patented, fully disposable, pre-sterilized implant & instrumentation system designed to enhance operating room efficiencies.
“BME is aggresively driving innovation in the area of Nitinol Shape Memory systems for small bone fixation,” states Keith M. Peeples, President & CEO of BME. “We saw great success with the game-changing technologies behind the Speed(TM) Continuous Active Compression System. The Speed Shift(TM) builds upon that foundation and give surgeons more anatomically-shaped implant options. Our mission is to design and manufacture implants that significantly enhance the healing of bone without compromise.”
BME, Inc. is the only U.S. manufacturer of Nitinol metal implants for musculoskeletal fixation. BME has led the innovation and advancement of Nitinol implants and patented disposable instrumentation in the U.S. market. BME continues to develop new standards for manufacturing processes while defining new parameters for product development with emphasis on education of our surgeon communities on the benefits of BME shape memory technologies.
SOURCE BME, Inc.